February 1, 2012

PV-10: A Melanoma Therapeutic in the Pipeline

In an article appearing on page 41 of the January 2012 edition of Practical Dermatology, Sanjiv Agarwala, M.D. answers questions regarding treating melanoma with PV-10 and his experience with administering PV-10.

December 21, 2011

John Mauldin Reports On Provectus

Provectus's cancer drug PV-10 (Rose Bengal) was discussed in a December 20, 2011 article titled "Catastrophic Success" appearing in John Mauldin's Out of the Box newsletter.

November 11, 2011

Emerging Biotech Companies Discuss What's in the Pipeline at NYSSA Conference

Provectus CEO Craig Dees, PhD will be presenting at the New York Society of Security Analysts' 15th Annual Biotech and Specialty Pharmaceuticals Conference on November 30, 2011 in New York City.

October 12, 2011

Journal of Surgical Oncology Articles Cover PV-10

Two recent articles in the Journal of Surgical Oncology give very positive reports on PV-10 for metastatic melanoma.

October 10, 2011

New Agents Stir Interest in Intralesional Therapy for Cutaneous Metastatic Melanoma

An article appearing in the September 2011 edition of Cancer Watch discusses the recent rise in interest in using intralesional therapies for treating metastatic melanoma.

October 4, 2011

Two Medical News Today Articles Cover PV-10

Medical News Today published two articles on September 29th covering PV-10 for melanoma and liver cancer.